Nivolumab, ipilimumab, cabozantinib, pembrolizumab, axitinib, lenvatinib clinical trials

Randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma

This study looks at different drug combinations for advanced kidney cancer to find the best treatment. It compares immune-boosting drugs with or without targeted therapies, aiming to improve survival and stop the cancer from growing.